Clinical Trial

CW-301 FIH Study of CAN016

Name: CW-301 FIH Study of CAN016 — clinical trial record (NCT07664150)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

A Phase I/II, Open-Label, Non-Randomized, Multi-Centre First-in-Human Study of CAN016 in Patients with Advanced Solid Tumors

Protocol Amendment History 1 change

critical Recruitment opened 2026-07-02

Trial Details

NCT Number	NCT07664150
Lead Sponsor	Canwell Biotech Limited
Conditions	Patients With Advanced Solid Tumors
Enrollment	90 participants
Start Date	2026-06-18
Primary Completion	2028-12-30 (estimated)
Study Completion	2029-12-30 (estimated)
Updated on ClinicalTrials.gov	2026-07-01